These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3927353)

  • 1. Chlordiazepoxide attenuates response suppression induced by corticotropin-releasing factor in the conflict test.
    Britton KT; Morgan J; Rivier J; Vale W; Koob GF
    Psychopharmacology (Berl); 1985; 86(1-2):170-4. PubMed ID: 3927353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y blocks anxiogenic-like behavioral action of corticotropin-releasing factor in an operant conflict test and elevated plus maze.
    Britton KT; Akwa Y; Spina MG; Koob GF
    Peptides; 2000 Jan; 21(1):37-44. PubMed ID: 10704717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common mechanisms underlying the proconflict effects of corticotropin-releasing factor, a benzodiazepine inverse agonist and electric foot-shock.
    De Boer SF; Katz JL; Valentino RJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):335-42. PubMed ID: 1625207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotropin releasing factor and amphetamine exaggerate partial agonist properties of benzodiazepine antagonist Ro 15-1788 in the conflict test.
    Britton KT; Lee G; Koob GF
    Psychopharmacology (Berl); 1988; 94(3):306-11. PubMed ID: 3128805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcohol reverses the proconflict effect of corticotropin-releasing factor.
    Thatcher-Britton K; Koob GF
    Regul Pept; 1986 Dec; 16(3-4):315-20. PubMed ID: 3031744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The modified Geller-Seifter test in rats was insensitive to GABAB receptor positive modulation or blockade, or 5-HT1A receptor activation.
    Paterson NE; Hanania T
    Behav Brain Res; 2010 Mar; 208(1):258-64. PubMed ID: 20006648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Destruction of the locus coeruleus or the dorsal NE bundle does not alter the release of punished responding by ethanol and chlordiazepoxide.
    Koob GF; Thatcher-Britton K; Britton DR; Roberts DC; Bloom FE
    Physiol Behav; 1984 Sep; 33(3):479-85. PubMed ID: 6542682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticotropin-releasing factor and defensive withdrawal: inhibition of monoamine oxidase prevents habituation to chronic stress.
    Ward HE; Johnson EA; Goodman IJ; Birkle DL; Cottrell DJ; Azzaro AJ
    Pharmacol Biochem Behav; 1998 May; 60(1):209-15. PubMed ID: 9610944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnane steroid alphaxalone attenuates anxiogenic behavioral effects of corticotropin releasing factor and stress.
    Britton KT; McLeod S; Koob GF; Hauger R
    Pharmacol Biochem Behav; 1992 Feb; 41(2):399-403. PubMed ID: 1315440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activating and 'anxiogenic' effects of corticotropin releasing factor are not inhibited by blockade of the pituitary-adrenal system with dexamethasone.
    Britton KT; Lee G; Dana R; Risch SC; Koob GF
    Life Sci; 1986 Oct; 39(14):1281-6. PubMed ID: 3489874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of FG 7142 and RO 15-1788 on the release of punished responding produced by chlordiazepoxide and ethanol in the rat.
    Koob GF; Braestrup C; Thatcher Britton K
    Psychopharmacology (Berl); 1986; 90(2):173-8. PubMed ID: 3097697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlordiazepoxide attenuates stress-induced accumulation of corticotropin-releasing factor mRNA in the paraventricular nucleus.
    Imaki T; Vale W
    Brain Res; 1993 Oct; 623(2):223-8. PubMed ID: 8221103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiolytic-like effect of neuropeptide Y (NPY), but not other peptides in an operant conflict test.
    Heilig M; McLeod S; Koob GK; Britton KT
    Regul Pept; 1992 Sep; 41(1):61-9. PubMed ID: 1360689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulant and anxiogenic effects of corticotropin releasing factor.
    Koob GF; Thatcher-Britton K
    Prog Clin Biol Res; 1985; 192():499-506. PubMed ID: 3878524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticotropin releasing factor (CRF) receptor antagonist blocks activating and 'anxiogenic' actions of CRF in the rat.
    Britton KT; Lee G; Vale W; Rivier J; Koob GF
    Brain Res; 1986 Mar; 369(1-2):303-6. PubMed ID: 3008937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of CRF(2) receptors produces anxiolytic behavior in animal models of anxiety.
    Takahashi LK; Ho SP; Livanov V; Graciani N; Arneric SP
    Brain Res; 2001 Jun; 902(2):135-42. PubMed ID: 11384606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 5-HT1A receptor ligands in a modified Geller-Seifter conflict model in the rat.
    King CM; Gommans J; Joordens RJ; Hijzen TH; Maes RA; Olivier B
    Eur J Pharmacol; 1997 May; 325(2-3):121-8. PubMed ID: 9163558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide.
    Swerdlow NR; Geyer MA; Vale WW; Koob GF
    Psychopharmacology (Berl); 1986; 88(2):147-52. PubMed ID: 3081925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat.
    Spina MG; Merlo-Pich E; Akwa Y; Balducci C; Basso AM; Zorrilla EP; Britton KT; Rivier J; Vale WW; Koob GF
    Psychopharmacology (Berl); 2002 Mar; 160(2):113-21. PubMed ID: 11875628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphetamine potentiation of anti-conflict action of chlordiazepoxide.
    Lerner T; Feldon J; Myslobodsky MS
    Pharmacol Biochem Behav; 1986 Feb; 24(2):241-6. PubMed ID: 3513210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.